08:00 , Nov 10, 2014 |  BC Week In Review  |  Company News

CellaVision management update

CellaVision AB (SSE:CEVI), Lund, Sweden   Business: Diagnostic   Hired: Zlatko Rihter as president and CEO, effective no later than Feb. 1, 2015, currently EVP and head of global sales and marketing at Origio A/S...
07:00 , May 12, 2014 |  BC Week In Review  |  Company News

CellaVision management update

CellaVision AB (SSE:CEVI), Lund, Sweden   Business: Diagnostic   Departing: Yvonne Martensson as president and CEO until a successor is appointed or Dec. 31 at the latest  ...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Company News

NeuroVive management update

NeuroVive Pharmaceutical AB (SSE:NVP), Lund, Sweden   Business: Neurology   Hired: Catharina Johansson as CFO, effective Dec. 1, formerly interim CFO of CellaVision AB ; she succeeds Christian Svensson  ...
07:00 , Apr 29, 2013 |  BC Week In Review  |  Company News

CellaVision management update

CellaVision AB (SSE:CEVI), Lund, Sweden   Business: Diagnostic   Hired: Magnus Blixt as CFO, effective May 2, formerly business demand manager at SFK AB; he succeeds acting CFO Sven-Ake Henningsson, who remains a director  ...
07:00 , Jul 9, 2012 |  BC Week In Review  |  Company News

CellaVision management update

CellaVision AB (SSE:CEVI), Lund, Sweden   Business: Diagnostic   Resigning: CFO Johan Wennerholm, effective the end of September; Sven-Ake Henningsson, a director, will serve as acting CFO  ...
07:00 , Jun 18, 2012 |  BC Week In Review  |  Company News

CellaVision management update

CellaVision AB (SSE:CEVI), Lund, Sweden   Business: Diagnostic   Transitioned: Peter Wilson to president of CellaVision North America from marketing manager, effective Sept. 1; he succeeds Dave Autry  ...
08:00 , Jan 17, 2011 |  BC Week In Review  |  Company News

CellaVision management update

CellaVision AB (SSE:CEVI), Lund, Sweden   Business: Diagnostic   Hired: Stefan Bengtsson as COO, formerly CEO of Presona AB  ...
08:00 , Dec 7, 2009 |  BC Week In Review  |  Clinical News

CellaVision DM1200 regulatory update

FDA granted market clearance for CellaVision's CellaVision DM1200, a diagnostic test to provide a preliminary differential count of peripheral blood. The company plans to launch the product in the U.S. next quarter. CellaVision DM1200, which...